Loading…
Brooks Laboratories (BROOKS)₹65.75−0.32%Pharmaceuticals
At the end of the Jun 2026 quarter, Brooks Laboratories' shareholders were: promoters 52.67%, DIIs 10.35%, public 36.98%. Promoter holding is unchanged on the quarter. It had 11,156 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 63.64% | 63.64% | 63.64% | 63.64% | 63.64% | 59.11% | 52.67% | 52.67% | 52.67% | 52.67% | 52.67% | 52.67% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% | 0.01% | 0.05% | 0.00% | 0.01% | 0.09% | 0.17% | 0.00% |
| DIIs | 2.45% | 3.84% | 3.84% | 3.84% | 3.84% | 3.84% | 10.35% | 10.35% | 10.35% | 10.35% | 10.35% | 10.35% |
| Public | 33.91% | 32.52% | 32.52% | 32.52% | 32.50% | 37.04% | 36.93% | 36.98% | 36.97% | 36.89% | 36.81% | 36.98% |
| Number of shareholders | 10,681 | 10,024 | 11,427 | 11,538 | 11,277 | 10,517 | 10,533 | 10,313 | 10,074 | 10,528 | 10,736 | 11,156 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Atul Ranchal | Promoter | 19.23% | 0.00 |
| Rajesh Mahajan | Promoter | 17.37% | 0.00 |
| Quant Mutual Fund - Quant Business Cycle Fund | DII | 9.96% | 0.00 |
| Erwin Mahajan | Promoter | 4.08% | 0.00 |
| Rajni Ranchal | Promoter | 2.93% | 0.00 |
| Savvy Ranchal | Promoter | 2.69% | 0.00 |
| Aryan Mahajan | Promoter | 2.48% | 0.00 |
| Saras Gupta | Promoter | 2.35% | 0.00 |
| Selina Ranchal | Promoter | 1.53% | 0.00 |
| Saumik Ketankumar Doshi | Public | 1.21% | 0.00 |
| One Up Financial Consultants Pvt Ltd | Public | 1.01% | −0.13 |
| Ramesh Thakurdas Jaisinghani | Public | Exited | — |
| Davinder Kumari | Promoter | 0.00% | 0.00 |
Promoters held 52.67% of Brooks Laboratories at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.00% (down 0.17 percentage points from 0.17% a quarter earlier) and domestic institutions (DIIs) held 10.35% (unchanged at 10.35% a quarter earlier).
Brooks Laboratories had 11,156 shareholders at the end of the Jun 2026 quarter, against 10,313 a year earlier.
Quant Mutual Fund - Quant Business Cycle Fund (DII) held 9.96% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.